Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: A multi-channel near-infrared spectroscopy study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 49, Issue , 2014, Pages 63-69

  Chou, Po Han ^a,b   Koike, Shinsuke ^a,c   Nishimura, Yukika ^a   Kawasaki, Shingo ^a,d   Satomura, Yoshihiro ^a   Kinoshita, Akihide ^a   Takizawa, Ryu ^a,e   Kasai, Kiyoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HITACHI LTD   (Japan)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Duration of untreated psychosis (DUP); Near Infrared Spectroscopy (NIRS); Schizophrenia; Verbal fluency test (VFT)

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; DIAZEPAM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD FLOW; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FRONTOTEMPORAL REGION; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HEMODYNAMICS; HUMAN; INFERIOR FRONTAL GYRUS; JAPAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NEAR INFRARED SPECTROSCOPY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTCENTRAL GYRUS; PRIMARY MOTOR CORTEX; PSYCHOSIS; RATING SCALE; RIGHT HEMISPHERE; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS; VERBAL FLUENCY TEST; BRAIN MAPPING; COMPLICATION; DRUG EFFECTS; FRONTAL LOBE; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOTIC DISORDERS; TEMPORAL LOBE; TIME TO TREATMENT; VASCULARIZATION; YOUNG ADULT;

ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FRONTAL LOBE; HUMANS; MALE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPECTROSCOPY, NEAR-INFRARED; TEMPORAL LOBE; TIME-TO-TREATMENT; YOUNG ADULT;

EID: 84889038090     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.11.009     Document Type: Article

References (66)

1. Addington J., Van Mastrigt S., Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004, 34:277-284.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, D.C. U.S.A. 4th ed.
3. Amminger G.P., Edwards J., Brewer W.J., Harrigan S., McGorry P.D. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res 2002, 54:223-230.
4. Barnes T.R., Leeson V.C., Mutsatsa S.H., Watt H.C., Hutton S.B., Joyce E.M. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. Br J Psychiatry 2008, 193:203-209.
5. Browne S., Larkin C., O'Callaghan E. Outcome studies in schizophrenia. Ir J Psychol Med 1999, 16:140-144.
6. Chang W.C., Hui C.L., Tang J.Y., Wong G.H., Chan S.K., Lee E.H., et al. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Psychol Med 2012, 1-11.
7. Crespo-Facorro B., Roiz-Santianez R., Pelayo-Teran J.M., Gonzalez-Blanch C., Perez-Iglesias R., Gutierrez A., et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res 2007, 91:87-96.
8. Crespo-Facorro B., Roiz-Santianez R., Pelayo-Teran J.M., Rodriguez-Sanchez J.M., Perez-Iglesias R., Gonzalez-Blanch C., et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. Neuroimage 2007, 35:1613-1623.
9. Cuesta M.J., Garcia de Jalon E., Campos M.S., Ibanez B., Sanchez-Torres A.M., Peralta V. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr Res 2012, 141:222-227.
10. Esterberg M., Compton M. Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients. Psychiatry Res 2012, 197:23-28.
11. Fannon D., Chitnis X., Doku V., Tennakoon L., O'Ceallaigh S., Soni W., et al. Features of structural brain abnormality detected in first-episode psychosis. Am J Psychiatry 2000, 157:1829-1834.
12. Ferrari M., Quaresima V. A brief review on the history of human functional near-infrared spectroscopy (fNIRS) development and fields of application. Neuroimage 2012, 63:921-935.
13. Galderisi S., Davidson M., Kahn R.S., Mucci A., Boter H., Gheorghe M.D., et al. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 2009, 115:104-114.
14. Galinska B., Szulc A., Tarasow E., Kubas B., Dzienis W., Czernikiewicz A., et al. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Med Sci Monit 2009, 15:CR82-CR88.
15. Gaynor K., Dooley B., Lawlor E., Lawoyin L.R., O'Callaghan E. Cognitive deterioration and duration of untreated psychosis. Early Interv Psychiatry 2009, 3:157-160.
16. Goldberg T.E., Burdick K.E., McCormack J., Napolitano B., Patel R.C., Sevy S.M., et al. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr Res 2009, 107:262-266.
17. Heinzel S., Metzger F.G., Ehlis A.C., Korell R., Alboji A., Haeussinger F.B., et al. Aging-related cortical reorganization of verbal fluency processing: a functional near-infrared spectroscopy study. Neurobiol Aging 2013, 34:439-450.
18. Hietala J., Cannon T.D., van Erp T.G., Syvalahti E., Vilkman H., Laakso A., et al. Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia. Schizophr Res 2003, 64:79-81.
19. Ho B.C., Alicata D., Ward J., Moser D.J., O'Leary D.S., Arndt S., et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003, 160:142-148.
20. Ho B.C., Alicata D., Mola C., Andreasen N.C. Hippocampus volume and treatment delays in first-episode schizophrenia. Am J Psychiatry 2005, 162:1527-1529.
21. Hoff A.L., Sakuma M., Razi K., Heydebrand G., Csernansky J.G., DeLisi L.E. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000, 157:1824-1828.
22. Hoffman R.E., McGlashan T.H. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophr Bull 1993, 19:119-140.
23. Job D.E., Whalley H.C., McConnell S., Glabus M., Johnstone E.C., Lawrie S.M. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 2002, 17:880-889.
24. Jobsis F.F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977, 198:1264-1267.
25. Joyce E., Hutton S., Mutsatsa S., Gibbins H., Webb E., Paul S., et al. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry 2002, 181:S38-S44.
26. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Lee C.U., Ciszewski A.A., et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003, 160:156-164.
27. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
28. Keshavan M.S., Haas G.L., Kahn C.E., Aguilar E., Dick E.L., Schooler N.R., et al. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?. J Psychiatr Res 1998, 32:161-167.
29. Kishimoto T., Robenzadeh A., Leucht C., Leucht S., Watanabe K., Mimura M., et al. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophr Bull 2013 (Epub ahead of print, in press).
30. Koike S., Takizawa R., Nishimura Y., Takano Y., Takayanagi Y., Kinou M., et al. Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis. Schizophr Res 2011, 132:54-61.
31. Koike S., Takano Y., Iwashiro N., Satomura Y., Suga M., Nagai T., et al. A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project. Schizophr Res 2013, 143:116-124.
32. Lappin J.M., Morgan K., Morgan C., Hutchison G., Chitnis X., Suckling J., et al. Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res 2006, 83:145-153.
33. Lappin J.M., Morgan K.D., Morgan C., Dazzan P., Reichenberg A., Zanelli J.W., et al. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res 2007, 95:103-110.
34. Leeson V.C., Barnes T.R., Harrison M., Matheson E., Harrison I., Mutsatsa S.H., et al. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr Bull 2010, 36:400-409.
35. Lehman A.F., Lieberman J.A., Dixon L.B., McGlashan T.H., Miller A.L., Perkins D.O., et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004, 161:1-56.
36. Malla A.K., Bodnar M., Joober R., Lepage M. Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res 2011, 125:13-20.
37. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005, 62:975-983.
38. Matsuoka K., Uno M., Kasai K., Koyama K., Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 2006, 60:332-339.
39. McGlashan T.H. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988, 14:515-542.
40. McGlashan T.H. Is active psychosis neurotoxic?. Schizophr Bull 2006, 32:609-613.
41. Meagher D.J., Quinn J.F., Bourke S., Linehan S., Murphy P., Kinsella A., et al. Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population. Psychiatry Res 2004, 126:217-227.
42. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
43. Onitsuka T., Shenton M.E., Salisbury D.F., Dickey C.C., Kasai K., Toner S.K., et al. Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study. Am J Psychiatry 2004, 161:1603-1611.
44. Penttila M., Jaaskelainen E., Haapea M., Tanskanen P., Veijola J., Ridler K., et al. Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophr Res 2010, 123:145-152.
45. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005, 162:1785-1804.
46. Rapp C., Studerus E., Bugra H., Aston J., Tamagni C., Walter A., et al. Duration of untreated psychosis and cognitive functioning. Schizophr Res 2013, 145:43-49.
47. Rund B.R., Melle I., Friis S., Johannessen J.O., Larsen T.K., Midboe L.J., et al. The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr Res 2007, 91:132-140.
48. Sato H., Yahata N., Funane T., Takizawa R., Katura T., Atsumori H., et al. A NIRS-fMRI investigation of prefrontal cortex activity during a working memory task. Neuroimage 2013, 83C:158-173.
49. Schimmelmann B.G., Huber C.G., Lambert M., Cotton S., McGorry P.D., Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res 2008, 42:982-990.
50. Shattuck D.W., Mirza M., Adisetiyo V., Hojatkashani C., Salamon G., Narr K.L., et al. Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage 2008, 39:1064-1080.
51. Singh A.K., Dan I. Exploring the false discovery rate in multichannel NIRS. Neuroimage 2006, 33:542-549.
52. Singh S.P., Cooper J.E., Fisher H.L., Tarrant C.J., Lloyd T., Banjo J., et al. Determining the chronology and components of psychosis onset: the Nottingham Onset Schedule (NOS). Schizophr Res 2005, 80:117-130.
53. Strangman G., Boas D.A., Sutton J.P. Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 2002, 52:679-693.
54. Suto T., Fukuda M., Ito M., Uehara T., Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol Psychiatry 2004, 55:501-511.
55. Takahashi T., Suzuki M., Tanino R., Zhou S.Y., Hagino H., Niu L., et al. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res 2007, 154:209-219.
56. Takizawa R., Kasai K., Kawakubo Y., Marumo K., Kawasaki S., Yamasue H., et al. Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophr Res 2008, 99:250-262.
57. Takizawa R., Hashimoto K., Tochigi M., Kawakubo Y., Marumo K., Sasaki T., et al. Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:491-498.
58. Takizawa R., Tochigi M., Kawakubo Y., Marumo K., Sasaki T., Fukuda M., et al. Association between catechol-O-methyltrasferase Val108/158Met genotype and prefrontal hemodynamic response in schizophrenia. PLoS One 2009, 4:e5495.
59. Takizawa R., Fukuda M., Kawasaki S., Kasai K., Mimura M., Pu S., et al. Neuroimaging-aided differential diagnosis of the depressive state. Neuroimage 2013 (Epub ahead of print, in press).
60. Tirupati N.S., Rangaswamy T., Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry 2004, 38:339-343.
61. Townsend L.A., Norman R.M., Malla A.K., Rychlo A.D., Ahmed R.R. Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psychiatry Res 2002, 113:69-81.
62. Tsuzuki D., Jurcak V., Singh A.K., Okamoto M., Watanabe E., Dan I. Virtual spatial registration of stand-alone fNIRS data to MNI space. Neuroimage 2007, 34:1506-1518.
63. Wang J., Hirayasu Y., Hokama H., Tanaka S., Kondo T., Zhang M., et al. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia. Psychiatry Clin Neurosci 2005, 59:209-214.
64. Warren J.E., Crinion J.T., Lambon Ralph M.A., Wise R.J. Anterior temporal lobe connectivity correlates with functional outcome after aphasic stroke. Brain 2009, 132:3428-3442.
65. Wood S.J., Berger G.E., Lambert M., Conus P., Velakoulis D., Stuart G.W., et al. Prediction of functional outcome 18months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2006, 63:969-976.
66. Wyatt R.J. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991, 17:325-351.